American Society of Clinical Oncology (ASCO) Market Research Report
Background
The American Society of Clinical Oncology (ASCO) is a professional organization founded in 1964, representing physicians across all oncology sub-specialties who care for individuals with cancer. With nearly 45,000 members worldwide, ASCO is dedicated to advancing cancer care through research, education, and the promotion of high-quality patient care. Its mission is to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO's vision encompasses a global community of oncology professionals committed to improving cancer care and prevention.
Key Strategic Focus
ASCO's strategic focus centers on several core objectives:
- Research and Education: Providing educational resources for cancer physicians and other healthcare professionals, including scientific meetings, educational conferences, professional workshops, and special symposia.
- Publications: Publishing numerous journals, books, newsletters, and online resources, such as the Journal of Clinical Oncology (JCO), JCO Oncology Practice, JCO Global Oncology, JCO Clinical Cancer Informatics, and JCO Precision Oncology.
- Advocacy and Policy: Advocating for policies that increase and provide access to high-quality cancer care, and supporting increased clinical and translational research to improve the care and treatment of people living with cancer.
- Global Collaboration: Partnering with organizations like the American Cancer Society to create comprehensive resources for patients and healthcare professionals.
Financials and Funding
As a non-profit organization, ASCO's financials are focused on supporting its mission. In the fiscal year 2021, ASCO reported revenue of $107.6 million. The organization is supported by its affiliate, the Conquer Cancer Foundation, which funds groundbreaking research and education across cancer's full continuum.
Pipeline Development
ASCO does not develop products or conduct clinical trials; instead, it focuses on supporting and disseminating research findings. Through its publications and educational programs, ASCO plays a pivotal role in advancing oncology research and practice.
Technological Platform and Innovation
ASCO leverages various technological platforms to enhance its educational and research initiatives:
- CancerLinQ™: A data platform initiative that collects and analyzes data from patient encounters to improve the quality of cancer care.
- Cancer.Net: A patient information website supported by the Conquer Cancer Foundation, providing authoritative cancer information.
- JCO Clinical Cancer Informatics: A journal publishing clinically relevant research based on biomedical informatics methods applied to cancer-related data.
Leadership Team
ASCO's leadership comprises professionals dedicated to advancing cancer care:
- Clifford A. Hudis, MD: Chief Executive Officer of ASCO; Executive Vice Chair of Conquer Cancer, the ASCO Foundation; and Chair of CancerLinQ.
- Nancy R. Daly: Chief Executive Officer of Conquer Cancer, the ASCO Foundation, and Executive Vice President of ASCO.
- Carmen Jackson: Interim Chief Executive Officer of CancerLinQ and Executive Vice President of ASCO.
- Julie R. Gralow, MD: Chief Medical Officer and Executive Vice President of ASCO.
Competitor Profile
ASCO operates in a collaborative environment with various organizations dedicated to cancer care and research. While it does not have direct competitors, it collaborates with entities such as the American Cancer Society to enhance cancer care and prevention efforts.
Strategic Collaborations and Partnerships
ASCO's strategic collaborations include:
- American Cancer Society (ACS): Collaborating to create a single, online resource for authoritative cancer information, with ASCO's oncologists contributing and vetting content.
- Conquer Cancer Foundation: Supporting ASCO by funding groundbreaking research and education across cancer's full continuum.
Operational Insights
ASCO's operational strategies focus on:
- Educational Programs: Offering scientific meetings, educational conferences, professional workshops, and special symposia to enhance oncology education.
- Advocacy: Advocating for policies that increase and provide access to high-quality cancer care.
- Global Collaboration: Partnering with organizations like the American Cancer Society to create comprehensive resources for patients and healthcare professionals.
Strategic Opportunities and Future Directions
ASCO's strategic roadmap includes:
- Expanding Educational Initiatives: Enhancing educational programs to address emerging challenges in oncology care.
- Advocacy for Policy Change: Continuing to advocate for policies that improve access to high-quality cancer care.
- Strengthening Global Partnerships: Building on collaborations with organizations like the American Cancer Society to enhance cancer care and prevention efforts worldwide.
Contact Information
- Website: www.asco.org
- LinkedIn: American Society of Clinical Oncology